ANTX

Latest SEC Filings & News for ANTX

2 most recent filings and news items mentioning ANTX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ANTX/news?limit=20"

Pull ANTX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

AN2 Therapeutics Reports Positive Data for Oral Chagas Disease Treatment

AN2 Therapeutics announced positive results for AN2-502998, achieving 100% parasite elimination in nonhuman primates with a favorable safety profile in Phase 1 testing. The company plans to advance the oral CPSF3 inhibitor to Phase 2 studies for chronic Chagas disease, addressing

View filing at SEC.gov →

Anteris Technologies establishes $250M at-the-market equity offering program

Anteris Technologies Global Corp. entered into a Common Stock Sales Agreement with TD Securities to issue up to $250 million in shares through an at-the-market offering. The agreement provides the company with flexible capital raising capacity under its existing S-3 registration

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.